|
Table 7: Frequency distribution of clinical stages according to the American Joint Committee on Cancer (AJCC-2017) of patients with oral cavity cancer in the INCan. |
|||||||
|
Clinical stage |
Men n (%) |
Women n (%) |
Subtotal n (%) |
fi |
hi |
Fi |
Hi |
|
I |
7 (5.60) |
11 (11.60) |
18 (8.1) |
18 |
0.081 |
18 |
0.081 |
|
II |
13 (10.30) |
9 (9.50) |
22 (10.0) |
22 |
0.100 |
40 |
0.181 |
|
III |
19 (15.10) |
22 (23.20) |
41 (18.5) |
41 |
0.185 |
81 |
0.366 |
|
IVA |
23 (18.30) |
15 (15.80) |
38 (17.2) |
38 |
0.172 |
119 |
0.538 |
|
IVB |
50 (39.70) |
30 (31.60) |
80 (36.2) |
80 |
0.362 |
199 |
0.900 |
|
IVC |
10 (7.90) |
1 (1.10) |
11 (5.0) |
11 |
0.050 |
210 |
0.950 |
|
No stage |
4 (3.20) |
7 (7.40) |
11 (5.0) |
11 |
0.050 |
221 |
1.000 |
|
Total |
126 (57.01) |
95 (42.99) |
221 (100.0) |
221 |
1 |
|
|
|
Confidence level of 95% (p < 0.05). fi = absolute frequency, hi = relative frequency, Fi = cumulative absolute frequency, Hi = cumulative relative frequency. Source: Database of the Department of Head and Neck Surgery of the INCan. |
|||||||